TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the Flic flagellin of Salmonella Typhimurium

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue SUPPL. 1, 2011, Pages 167-171

  Camacho, Ariane Guglielmi Ariza ^a   Teixeira, Laís Helena ^a,b   Bargieri, Daniel Youssef ^a   Boscardin, Silvia Beatriz ^b   Soares, Irene da Silva ^b   Nussenzweig, Ruth Sonntag ^c   Nussenzweig, Victor ^c   Rodrigues, Mauricio Martin ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CS protein; Flagellin; P. vivax; TLR5

Indexed keywords

EPITOPE; ESCHERICHIA COLI PROTEIN; FLAGELLIN; FLIC PROTEIN, E COLI; HYBRID PROTEIN; MALARIA VACCINE; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; TOLL LIKE RECEPTOR 5;

ANIMAL; ARTICLE; C57BL MOUSE; IMMUNOLOGY; METABOLISM; MOUSE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIBODIES, PROTOZOAN; EPITOPES, B-LYMPHOCYTE; ESCHERICHIA COLI PROTEINS; FLAGELLIN; IMMUNODOMINANT EPITOPES; MALARIA VACCINES; MALARIA, VIVAX; MICE; MICE, INBRED C57BL; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHIMURIUM; TOLL-LIKE RECEPTOR 5;

ESCHERICHIA COLI; MUS; PLASMODIUM VIVAX; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 80051712839     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000900021     Document Type: Article

References (23)

1. Abdulla S, Oberholzer R, Juma O, Kubhoja S, Machera F, Membi C, Omari S, Urassa A, Mshinda H, Jumanne A, Salim N, Shomari M, Aebi T, Schellenberg DM, Carter T, Villafana T, Demoitié MA, Dubois MC, Leach A, Lievens M, Vekemans J, Cohen J, Ballou WR, Tanner M 2008. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 359: 2533-2544.
2. Bargieri DY, Leite JA, Lopes SC, Sbrogio-Almeida ME, Braga CJ, Ferreira LC, Soares IS, Costa FT, Rodrigues MM 2010. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium. Vaccine 28: 2818-2826.
3. Bargieri DY, Rosa DS, Braga CJ, Carvalho BO, Costa FT, Espíndola NM, Vaz AJ, Soares IS, Ferreira LC, Rodrigues MM 2008. New malaria vaccine candidates based on the Plasmodium vivax merozoite surface protein-1 and the TLR-5 agonist Salmonella Ty- phimurium FliC flagellin. Vaccine 26: 6132-6142.
4. Bargieri DY, Soares IS, Costa FTM, Braga CJ, Ferreira LCS, Rodrigues MM 2011. Malaria vaccine development: are bacterial flagellin fusion proteins the bridge between mouse and humans? J Parasitol Res doi:10.1155/2011/965369.
5. Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J, Mshamu S, Lang T, Gould J, Dubois MC, Demoitié MA, Stallaert JF, Vansadia P, Carter T, Njuguna P, Awuondo KO, Malabeja A, Abdul O, Gesase S, Mturi N, Drakeley CJ, Savarese B, Villafana T, Ballou WR, Cohen J, Riley EM, Lemnge MM, Marsh K, von Seidlein L 2008. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 359: 2521-2532.
6. Cohen J, Nussenzweig V, Nussenzweig R, Vekemans J, Leach A 2010. From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum Vaccin 6: 90-96.
7. Feuillet V, Medjane S, Mondor I, Demaria O, Pagni PP, Galán JE, Flavell RA, Alexopoulou L 2006. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci USA 103: 12487-12492.
8. Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG Jr, RTS, S Vaccine Evaluation Group 2009. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis 200: 337-346.
9. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, Zavala F, Nussenzweig V 2006. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444: 937-940.
10. Letran SE, Lee SJ, Atif SM, Uematsu S, Akira S, McSorley SJ 2011. TLR5 functions as an endocytic receptor to enhance flagellin-specific adaptive immunity. Eur J Immunol 41: 29-38.
11. Lightfield KL, Persson J, Brubaker SW, Witte CE, von Moltke J, Dunipace EA, Henry T, Sun YH, Cado D, Dietrich WF, Monack DM, Tsolis RM, Vance RE 2008. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat Immunol 9: 1171-1178.
12. Malik A, Egan JE, Houghten RA, Sadoff JC, Hoffman SL 1991. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci USA 88: 3300-3304.
13. Mauduit M, Grüner AC, Tewari R, Depinay N, Kayibanda M, Chavatte JM, Franetich JF, Crisanti A, Mazier D, Snounou G, Rénia L 2009. A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PLoS ONE 4: e7717.
14. Mizel SB, Bates JT 2010. Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol 185: 5677-5682.
15. + clones from a malaria-immunized volunteer. Science 246: 1603-1606.
16. Nardin EH, Nussenzweig V, Nussenzweig RS, Collins WE, Harinasuta KT, Tapchaisri P, Chomcharn Y 1982. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med 156: 20-30.
17. Nussenzweig RS, Vanderberg J, Most H, Orton C 1967. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216: 160-162.
18. + T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sci USA 88: 7963-7967.
19. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 3: 579-585.
20. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341: 323-326.
21. Sanders CJ, Franchi L, Yarovinsky F, Uematsu S, Akira S, Núñez G, Gewirtz AT 2009. Induction of adaptive immunity by flagellin does not require robust activation of innate immunity. Eur J Immunol 39: 359-371.
22. Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, Liu G, Kavita U, Song L, Dark I, Shaw A 2010. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine 28: 8268-8274.
23. Vijay-Kumar M, Carvalho FA, Aitken JD, Fifadara NH, Gewirtz AT 2010. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin. Eur J Immunol 40: 3528-3534.